[1]
Bui, T.T.T. et al. 2026. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF FACIAL SEBORRHEIC DERMATITIS WITH ORAL ITRACONAZOLE COMBINED WITH TOPICAL TACROLIMUS 0.03% AT DONG NAI DERMATOLOGY HOSPITAL IN 2025. Cantho Journal of Medicine and Pharmacy. 98 (May 2026), 69–76. DOI:https://doi.org/10.58490/ctjump.2026i98.4557.